GLP-1 Weight Loss Readiness Quiz
Wondering if you qualify for GLP-1 weight loss medications like Ozempic, Wegovy, or Zepbound? This short readiness quiz walks through the factors clinicians commonly weigh, including your BMI, weight-related health conditions, and readiness to combine medication with lifestyle changes. It is educational only and is not a prescription or an eligibility decision, but it can help you prepare for a conversation with a healthcare professional.
Start quiz
Unlock your GLP-1 readiness result
See how the common eligibility factors clinicians weigh apply to your answers, and what to prepare before a conversation about GLP-1 weight-loss medication.
- Your readiness level based on BMI, conditions, and goals
- The eligibility factors a clinician typically reviews
- Safety considerations worth flagging before you start
- Baseline lab options to bring to your visit
Almost done
Check your inbox and click the confirmation link to join the waitlist.
Check your email to see your results
Your results are ready — you'll get two emails to unlock them:
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Your results are in the second email
Once you confirm, we send a second email with your unlock link — click it to see your full results.
The first email should arrive within a minute. Don't see it? Check your spam or promotions folder.
When to seek urgent care
Turn your answers into next steps
Recommended test
Why you got this result
| Score | Answer | Note |
|---|---|---|
No higher-scoring answers stood out — your responses pointed toward lower concern.
What this means
Patterns to watch
Frequently Asked Questions
Common questions about this quiz, what it covers, and what your results mean.
This quiz is for health education only. It cannot prescribe medication, diagnose any condition, or determine your eligibility for a GLP-1 medication. Only a licensed healthcare professional can decide whether a GLP-1 is appropriate for you. Do not start, stop, or change any medication, or obtain medication from unverified sources, based on this quiz.
These weight-loss GLP-1 medications are generally studied for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. A licensed clinician confirms eligibility after reviewing your history.
Ozempic is FDA-approved for type 2 diabetes, but clinicians also prescribe it off-label for weight loss. Whether it fits you is a decision a licensed clinician makes based on your health history; this quiz cannot determine eligibility.
Yes. Weight-management GLP-1 medications such as Wegovy, Zepbound, and Saxenda are approved for adults with overweight or obesity even without diabetes, subject to a clinician's evaluation.
Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved specifically for weight loss, and Saxenda is also approved. Ozempic and Mounjaro contain the same medicines at diabetes doses and are increasingly prescribed off-label for weight loss.
In clinical trials, adults taking semaglutide (Wegovy) lost about 15% of their body weight on average, and those on tirzepatide (Zepbound) lost roughly 20% or more, over about 16 months alongside lifestyle changes. Individual results vary and weight loss is usually gradual.
The dose is increased slowly over several weeks to limit side effects, so appetite changes often begin in the first few weeks while meaningful weight loss builds over months. Your clinician sets the schedule.
Wegovy and Zepbound are the versions approved for weight loss (Ozempic is the diabetes version of the same medicine as Wegovy). In trials, tirzepatide (Zepbound) produced the largest average weight loss, but the best choice depends on your health, tolerance, cost, and your clinician's guidance.
Most GLP-1 weight-loss medications are given as a once-weekly self-injection with a small pen; Saxenda is a daily injection, and an oral option is emerging. A pharmacist or clinician can show you how to use them.
Without insurance, brand-name GLP-1 weight-loss medications often cost more than $1,000 a month. Manufacturer savings programs, insurance coverage, and pharmacy options can lower the price, so it is worth comparing before you start.
Coverage varies widely and often requires prior authorization, and many plans cover these medicines for diabetes but not for weight loss. Out-of-pocket costs can be significant, so it is worth checking your plan early.
The most common side effects are nausea, vomiting, diarrhea, constipation, and stomach discomfort, which often ease over time. Serious effects are less common; discuss the risks with your clinician.
GLP-1 medications are generally avoided with a personal or family history of medullary thyroid cancer or MEN2, used with caution after pancreatitis, and are not used during pregnancy or breastfeeding. A clinician reviews your full history first.
Obesity is often treated as a long-term condition, and studies show many people regain weight after stopping because appetite returns. How long to stay on a GLP-1 is a decision to make with your clinician, ideally alongside lasting lifestyle changes.
Clinicians often review blood sugar and A1C, kidney and liver markers (a metabolic panel), and a lipid panel. Baseline labs help personalize treatment and monitor safety, and you can get them before your visit.